Artículos por temáticas

Enhancing Cardiovascular Autonomic Regulation in Parkinson's Disease Through Non-Invasive Interventions

Suthar A, Zemmar A, Krassioukov A, Ovechkin A.

Life (Basel). 2025 Aug 5;15(8):1244. doi: 10.3390/life15081244.

Genome-wide association analyses reveal susceptibility variants linked to Parkinson's disease in the South African population using inferred global and local ancestry

Step K, Leal TP, Waldo E, Madula L, Swart Y, Hernández CF, Kim JJ, Bandres-Ciga S; Global Parkinson’s Genetics Program (GP2); Mata IF, Bardien S.

medRxiv [Preprint]. 2025 Aug 2:2025.08.01.25331910. doi: 10.1101/2025.08.01.25331910.

Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Symptoms in Parkinson's Disease: Results from a Phase II Randomized Control Trial (STRIPE)

Smith MD, Portlock GE, Cullen A, Nodehi A, Drake MJ, Ben-Shlomo Y, Henderson EJ.

Mov Disord. 2025 Jul;40(7):1291-1296. doi: 10.1002/mds.30186. Epub 2025 Apr 17.

The cognitive and neurological implications of toxoplasma gondii infection: Evidence from a systematic review and meta-analysis

Kavakebian M, Ghandali T, Nasiri H, Ramezani-Moghadam F, Alizadeh S, Alizadeh S, Silakhor M, Rajabi M, Mirmazhari A, Asgarian P, Rahimi H, Karimi M, Moosazadeh M.

Acta Trop. 2025 Aug;268:107705. doi: 10.1016/j.actatropica.2025.107705. Epub 2025 Jun 21.

Ketogenic Metabolism in Neurodegenerative Diseases: Mechanisms of Action and Therapeutic Potential

Pawłowska M, Kruszka J, Porzych M, Garbarek J, Nuszkiewicz J.

Metabolites. 2025 Jul 31;15(8):508. doi: 10.3390/metabo15080508.

Can proton pump inhibitors increase the risk of sudden unexpected death in Parkinson's disease (SUDPAR)?

Menezes-Rodrigues FS, Tallo FS, Caricati-Neto A, Finsterer J, Scorza CA, Scorza FA.

Clinics (Sao Paulo). 2025 Jul 31;80:100721. doi: 10.1016/j.clinsp.2025.100721. Online ahead of print.

Comment on: Toward multidimensional evaluation of Pentoxifylline's role in Parkinson's disease

Yuan S, Zhang J.

Int Immunopharmacol. 2025 Aug 28;161:114990. doi: 10.1016/j.intimp.2025.114990. Epub 2025 Jun 6.

The Emerging Role of the Molecular Chaperone Clusterin in Parkinson's Disease

Carini G, Mohammed S, Filippini A, Ramazzina I, Russo I.

Int J Mol Sci. 2025 Jul 1;26(13):6351. doi: 10.3390/ijms26136351.

Polyphenolic protection: the role of mangiferin in mitigating neurodegeneration and neuroinflammation

Mustafa AM, Bastawesy GA, Hatem S, Moussa RA, Hal DM, Fawzy MH, Mansour MA, Abd El Hafeez MS.

Inflammopharmacology. 2025 Jul 22. doi: 10.1007/s10787-025-01854-3. Online ahead of print.

Aerobic exercise acutely increases EEG gamma power in the motor/sensorimotor areas during walking in people with Parkinson's disease

Orcioli-Silva D, Vitório R, Beretta VS, Souza Oliveira A, Conceição NRD, Nóbrega-Sousa P, Santos PCRD, Gobbi LTB, Barela JA.

Clin Neurophysiol. 2025 Jul;175:2110755. doi: 10.1016/j.clinph.2025.2110755. Epub 2025 May 17.

Strengths, Weaknesses, Opportunities, and Potential Threat Analysis of Targeting Leucine-Rich Repeat Kinase 2 for Parkinson's Disease Treatment: Status Quo and Quo Vadis

Dang C, Feng Z, Xu T, Li M, Wang Z, Song H, Wang RB.

J Med Chem. 2025 Jul 10;68(13):13148-13168. doi: 10.1021/acs.jmedchem.5c00013. Epub 2025 Jun 30.

Comparing the biopsychosocial impact of group singing and yoga activities in older adults living with Parkinson's disease

Good A, Pachete A, Gilmore S, Russo FA.

Sci Rep. 2025 Jul 23;15(1):26713. doi: 10.1038/s41598-025-09200-x.

Efficacy of cholinesterase inhibitors and memantine on symptoms not responsive to levodopa in patients affected by Parkinson's disease without dementia: a systematic review

Cani I, Grotteschi N, Calandra-Buonaura G, Guarino M, Guaraldi P, Giannini G, Baldelli L, Donati M, Cortelli P, Camerlingo MD, Nonino F, Sambati L.

BMJ Neurol Open. 2025 Aug 3;7(2):e001079. doi: 10.1136/bmjno-2025-001079. eCollection 2025.

Correction: Clinical progression and genetic pathways in body-first and brain-first Parkinson's disease

Passaretti M, Veréb D, Mijalkov M, Chang YW, Zhao H, Zufiria-Gerbolés B, Sun J, Volpe G, Rivera N, Bologna M, Pereira JB.

Mol Neurodegener. 2025 Aug 20;20(1):91. doi: 10.1186/s13024-025-00885-2.

Comorbid pathologies and their impact on progressive supranuclear palsy: current view

Jellinger KA.

J Neural Transm (Vienna). 2025 Aug 12. doi: 10.1007/s00702-025-03005-y. Online ahead of print.